Completion of the Human Papillomavirus Vaccine Series Among Insured Females Between 2006 and 2009HIRTH, Jacqueline M; TAN, Alai; WILKINSON, Gregg S et al.Cancer. 2012, Vol 118, Num 22, pp 5623-5629, issn 0008-543X, 7 p.Article

Correlates for Human Papillomavirus Vaccination of Adolescent Girls and Young Women in a Managed Care OrganizationCHUN CHAO; VELICER, Christine; SLEZAK, Jeff M et al.American journal of epidemiology. 2010, Vol 171, Num 3, pp 357-367, issn 0002-9262, 11 p.Article

Integrations of the hepatitis B virus (HBV) and human papillomavirus (hpv) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancersFERBER, M. J; MONTOYA, D. P; BRUIX, J et al.Oncogene (Basingstoke). 2003, Vol 22, Num 24, pp 3813-3820, issn 0950-9232, 8 p.Article

A Review of Prophylactic Human Papillomavirus Vaccines : Recommendations and Monitoring in the USDUNNE, Eileen F; DEBLINA DATTA, S; MARKOWITZ, Lauri E et al.Cancer. 2008, Vol 113, Num 10, pp 2995-3003, issn 0008-543X, 9 p., SUPArticle

Episomal and integrated human papillomavirus type 16 loads and anal intraepithelial neoplasia in HIV-seropositive menALVAREZ, Jennifer; POKOMANDY, Alexandra D. E; ROULEAU, Danielle et al.AIDS (London). 2010, Vol 24, Num 15, pp 2355-2363, issn 0269-9370, 9 p.Article

HPV group-and type-specific concordance in HPV infected sexual couplesGIOVANNELLI, Lucia; BELLAVIA, Carmelina; CAPRA, Giuseppina et al.Journal of medical virology. 2007, Vol 79, Num 12, pp 1882-1888, issn 0146-6615, 7 p.Article

Interaction of the HPV E7 proteins with the pCAF acetyltransferaseAVVAKUMOV, Nikita; TORCHIA, Joe; MYMRYK, Joe S et al.Oncogene (Basingstoke). 2003, Vol 22, Num 25, pp 3833-3841, issn 0950-9232, 9 p.Article

Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety DatalinkGEE, Julianne; NALEWAY, Allison; KLEIN, Nicola P et al.Vaccine. 2011, Vol 29, Num 46, pp 8279-8284, issn 0264-410X, 6 p.Article

Human Papillomavirus (HPV) Type 16 and Type 18 DNA Loads at Baseline and Persistence of Type-Specific Infection during a 2-Year Follow-UpLONG FU XI; HUGHES, James P; EDELSTEIN, Zoe R et al.The Journal of infectious diseases. 2009, Vol 200, Num 11, pp 1789-1797, issn 0022-1899, 9 p.Article

Effects of cytokines on long control region transcriptional activity in high-risk cutaneous human papillomavirus types 5 and 8DONALISIO, Manuela; POLI, Alice; CIVRA, Andrea et al.Archives of virology. 2010, Vol 155, Num 4, pp 583-587, issn 0304-8608, 5 p.Article

Impact of baseline covariates on the immunogenidty of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccineGIULIANO, Anna R; LAZCANO-PONCE, Eduardo; VUOCOLO, Scott C et al.The Journal of infectious diseases. 2007, Vol 196, Num 8, pp 1153-1162, issn 0022-1899, 10 p.Article

Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital wartsGROSS, G; PFISTER, H.Medical microbiology and immunology. 2004, Vol 193, Num 1, pp 35-44, issn 0300-8584, 10 p.Article

Systematic Analysis of the Amino Acid Residues of Human Papillomavirus Type 16 E7 Conserved Region 3 Involved in Dimerization and TransformationTODOROVIC, Biljana; MASSIMI, Paola; HUNG, Katherine et al.Journal of virology. 2011, Vol 85, Num 19, pp 10048-10057, issn 0022-538X, 10 p.Article

Lack of heterogeneity of HPV16 E7 sequence compared with HPV31 and HPV73 may be related to its unique carcinogenic propertiesSAFAEIAN, Mahboobeh; VAN DOORSLAER, Koenraad; SCHIFFMAN, Mark et al.Archives of virology. 2010, Vol 155, Num 3, pp 367-370, issn 0304-8608, 4 p.Article

Tissue-Spanning Redox Gradient-Dependent Assembly of Native Human Papillomavirus Type 16 VirionsCONWAY, Michael J; ALAM, Samina; RYNDOCK, Eric J et al.Journal of virology. 2009, Vol 83, Num 20, pp 10515-10526, issn 0022-538X, 12 p.Article

The PDZ Binding Motif of Human Papillomavirus Type 16 E6 Induces PTPN13 Loss, Which Allows Anchorage-Independent Growth and Synergizes with Ras for Invasive GrowthSPANOS, William C; HOOVER, Andrew; HARRIS, George F et al.Journal of virology. 2008, Vol 82, Num 5, pp 2493-2500, issn 0022-538X, 8 p.Article

Determination of human papillomavirus 16 physical status through E1/E6 and E2/E6 ratio analysisTSAKOGIANNIS, Dimitris; KYRIAKOPOULOU, Zaharoula; ANNA RUETHER, Irina Georgia et al.Journal of medical microbiology. 2014, Vol 63, Num 12, pp 1716-1723, issn 0022-2615, 8 p.Article

Functional implication of sequence variation in the long control region and E2 gene among human papillomavirus type 18 variantsLOPEZ-SAAVEDRA, Alejandro; GONZILEZ-MAYA, Leticia; PONCE-DE-LEON, Sergio et al.Archives of virology. 2009, Vol 154, Num 5, pp 747-754, issn 0304-8608, 8 p.Article

Functional Mapping of the Human Papillomavirus Type 16 El CistronLACE, Michael J; ANSON, James R; TUREK, Lubomir P et al.Journal of virology. 2008, Vol 82, Num 21, pp 10724-10734, issn 0022-538X, 11 p.Article

Cytology and Human Papillomavirus Testing 6 to 12 Months after ASCUS or LSIL Cytology in Organized Screening To Predict High-Grade Cervical Neoplasia between Screening RoundsTROPE, Ameli; SJOBORG, Katrine D; NYGARD, Mari et al.Journal of clinical microbiology (Print). 2012, Vol 50, Num 6, pp 1927-1935, issn 0095-1137, 9 p.Article

Oncogenic human papillomavirus (HPV) type distribution and HPV type 16 E6 variants in two Spanish population groups with different levels of HPV infection riskORTIZ, M; TORRES, M; MUNOZ, L et al.Journal of clinical microbiology (Print). 2006, Vol 44, Num 4, pp 1428-1434, issn 0095-1137, 7 p.Article

NFX1 Plays a Role in Human Papillomavirus Type 16 E6 Activation of NF_KB ActivityMEI XU; KATZENELLENBOGEN, Rachel A; GRANDORI, Carla et al.Journal of virology. 2010, Vol 84, Num 21, pp 11461-11469, issn 0022-538X, 9 p.Article

Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccineROWHANI-RAHBAR, Ali; MAO, Constance; HUGHES, James P et al.Vaccine. 2009, Vol 27, Num 41, pp 5612-5619, issn 0264-410X, 8 p.Article

Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccineMONSONEGO, J; CORTES, J; GREPPE, C et al.Vaccine. 2010, Vol 28, Num 51, pp 8065-8072, issn 0264-410X, 8 p.Article

Seroprevalence of human papillomavirus types 16 and 18 in the general population in Taiwan : Implication for optimal age of human papillomavirus vaccinationCHEN, Chih-Jung; VISCIDI, Raphael P; CHUANG, Chih-Hsien et al.Journal of clinical virology. 2007, Vol 38, Num 2, pp 126-130, issn 1386-6532, 5 p.Article